Active Ingredient History

  • Now
Cebranopadol is an opioid analgesic of the benzenoid class which is currently under development internationally by Grünenthal, a German pharmaceutical company, and its partner Depomed, a pharmaceutical company in the United States, for the treatment of a variety of different acute and chronic pain states. As of November 2014, it is in phase III clinical trials.   Wikipedia

  • SMILES: CN(C)[C@@]1(CC[C@]2(CC1)OCCc3c2[nH]c4ccc(F)cc34)c5ccccc5
  • Mol. Mass: 378.49
  • ALogP: 5.11
  • ChEMBL Molecule:
More Chemistry
6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine | cebranopadol | grt6005


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue